XML 21 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Statements of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating activities    
Net loss $ (10,359,350) $ (14,653,041)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 43,839 59,308
Non-cash lease expense 219,119 198,814
Stock-based compensation 870,180 1,080,642
Changes in assets and liabilities:    
Prepaid expenses and other current assets (240,103) (413,588)
Prepaid research and development expenses   (660,800)
Accounts payable (490,040) 168,558
Accrued expenses (1,383,683) 761,658
Lease liabilities (266,821) (239,694)
Net cash used in operating activities (11,606,859) (13,698,143)
Investing activities    
Purchases of property and equipment (2,197) (40,521)
Net cash used in investing activities (2,197) (40,521)
Financing activities    
Proceeds from issuance of common stock, net of issuance costs 28,707,011  
Proceeds from exercise of stock options 33,768  
Net cash provided by financing activities 28,740,779  
Net change in cash and cash equivalents 17,131,723 (13,738,664)
Cash and cash equivalents, beginning of period 47,870,619 90,254,890
Cash and cash equivalents, end of period $ 65,002,342 $ 76,516,226